Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study-Reference-Cited by-同舟云学术

Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: a phase II study

Published:1999-04 Issue:1 Volume:51 Page:27-33
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Jeremic Branislav,Shibamoto Yuta,Grujicic Danica,Milicic Biljana,Stojanovic Miroslav,Nikolic Nebojsa,Dagovic Aleksandar,Aleksandrovic Jasna

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference38 articles.

1. Cell-kinetic characteristics of humnan brain tumors;Assieti;Oncology,1990

2. Accelerated hyperfractionated radiotherapy for malignant gliomas;Buatti;Int. J. Radiat. Oncol. Biol. Phys.,1996

3. Comparison of post-operative radiotherapy and combined post-operative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas;Chang;Cancer,1983

4. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for the Research and Treatment of Cancer (EORTC);Cox;Int. J. Radiat. Oncol. Biol. Phys.,1995

5. MOP chemotherapy followed by radiotherapy for high grade glioma (abstr.);Coyle;Proc. Am. Soc. Clin. Oncol.,1995

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of preirradiation temozolomide in cases of high-grade gliomas: Our experience and review of literature;Journal of Cancer Research and Therapeutics;2023

2. Repurposing drugs in glioblastoma;New Insights Into Glioblastoma;2023

3. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo;Neuro-Oncology;2018-04-20

4. Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma;Neuro-Oncology;2017-10-12

5. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials;Neurotherapeutics;2017-01-20